Metal Imbalance in Neurodegenerative Diseases with a Specific Concern to the Brain of Multiple Sclerosis Patients

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2020 Dec 3

PMID 33266021

Citations 10

Authors

Jean-Philippe Dales

Sophie Desplat-Jego

Affiliations

Soon will be listed here.

Abstract

There is increasing evidence that deregulation of metals contributes to a vast range of neurodegenerative diseases including multiple sclerosis (MS). MS is a chronic inflammatory disease of the central nervous system (CNS) manifesting disability and neurological symptoms. The precise origin of MS is unknown, but the disease is characterized by focal inflammatory lesions in the CNS associated with an autoimmune reaction against myelin. The treatment of this disease has mainly been based on the prescription of immunosuppressive and immune-modulating agents. However, the rate of progressive disability and early mortality is still worrisome. Metals may represent new diagnostic and predictive markers of severity and disability as well as innovative candidate drug targets for future therapies. In this review, we describe the recent advances in our understanding on the role of metals in brain disorders of neurodegenerative diseases and MS patients.

Citing Articles

Diet and Nutrients in Rare Neurological Disorders: Biological, Biochemical, and Pathophysiological Evidence.

Briglia M, Allia F, Avola R, Signorini C, Cardile V, Romano G Nutrients. 2024; 16(18).

PMID: 39339713 PMC: 11435074. DOI: 10.3390/nu16183114.

Changes of Target Essential Trace Elements in Multiple Sclerosis: A Systematic Review and Meta-Analysis.

Stojsavljevic A, Jagodic J, Perovic T, Manojlovic D, Pavlovic S Biomedicines. 2024; 12(7).

PMID: 39062163 PMC: 11274787. DOI: 10.3390/biomedicines12071589.

The Effects of Fisetin and Curcumin on Oxidative Damage Caused by Transition Metals in Neurodegenerative Diseases.

Bjorklund G, Oliinyk P, Khavrona O, Lozynska I, Lysiuk R, Darmohray R Mol Neurobiol. 2024; 62(1):1225-1246.

PMID: 38970766 DOI: 10.1007/s12035-024-04321-2.

Cell Death and Neurodegenerative Diseases: Mechanisms and Cytoprotective Molecules.

Vejux A Int J Mol Sci. 2023; 24(14).

PMID: 37511220 PMC: 10380922. DOI: 10.3390/ijms241411465.

The Blood Concentration of Metallic Nanoparticles Is Related to Cognitive Performance in People with Multiple Sclerosis: An Exploratory Analysis.

de Oliveira M, Santinelli F, Lisboa-Filho P, Barbieri F Biomedicines. 2023; 11(7).

PMID: 37509462 PMC: 10376844. DOI: 10.3390/biomedicines11071819.

References

Kern M, Wisniewski M, Cabell L, Audesirk G . Inorganic lead and calcium interact positively in activation of calmodulin. Neurotoxicology. 2000; 21(3):353-63. View

Krezel A, Maret W . The Functions of Metamorphic Metallothioneins in Zinc and Copper Metabolism. Int J Mol Sci. 2017; 18(6). PMC: 5486060. DOI: 10.3390/ijms18061237. View

Yamanaka K, Minato N, Iwai K . Stabilization of iron regulatory protein 2, IRP2, by aluminum. FEBS Lett. 1999; 462(1-2):216-20. DOI: 10.1016/s0014-5793(99)01533-1. View

Takeda A . Movement of zinc and its functional significance in the brain. Brain Res Brain Res Rev. 2000; 34(3):137-48. DOI: 10.1016/s0165-0173(00)00044-8. View

Krebs N, Langkammer C, Goessler W, Ropele S, Fazekas F, Yen K . Assessment of trace elements in human brain using inductively coupled plasma mass spectrometry. J Trace Elem Med Biol. 2013; 28(1):1-7. DOI: 10.1016/j.jtemb.2013.09.006. View

Ackerman C, Lee S, Chang C . Analytical Methods for Imaging Metals in Biology: From Transition Metal Metabolism to Transition Metal Signaling. Anal Chem. 2016; 89(1):22-41. PMC: 5827935. DOI: 10.1021/acs.analchem.6b04631. View

Gaier E, Eipper B, Mains R . Copper signaling in the mammalian nervous system: synaptic effects. J Neurosci Res. 2012; 91(1):2-19. PMC: 3926505. DOI: 10.1002/jnr.23143. View

Skjorringe T, Moller L, Moos T . Impairment of interrelated iron- and copper homeostatic mechanisms in brain contributes to the pathogenesis of neurodegenerative disorders. Front Pharmacol. 2012; 3:169. PMC: 3456798. DOI: 10.3389/fphar.2012.00169. View

Wang Z, Wei X, Yang J, Suo J, Chen J, Liu X . Chronic exposure to aluminum and risk of Alzheimer's disease: A meta-analysis. Neurosci Lett. 2015; 610:200-6. DOI: 10.1016/j.neulet.2015.11.014. View

10.

Leskovjan A, Lanzirotti A, Miller L . Amyloid plaques in PSAPP mice bind less metal than plaques in human Alzheimer's disease. Neuroimage. 2009; 47(4):1215-20. PMC: 2746706. DOI: 10.1016/j.neuroimage.2009.05.063. View

11.

Ruiperez F, Mujika J, Ugalde J, Exley C, Lopez X . Pro-oxidant activity of aluminum: promoting the Fenton reaction by reducing Fe(III) to Fe(II). J Inorg Biochem. 2012; 117:118-23. DOI: 10.1016/j.jinorgbio.2012.09.008. View

12.

Liuzzi J, Cousins R . Mammalian zinc transporters. Annu Rev Nutr. 2004; 24:151-72. DOI: 10.1146/annurev.nutr.24.012003.132402. View

13.

Stewart T . Across the spectrum: integrating multidimensional metal analytics for in situ metallomic imaging. Metallomics. 2018; 11(1):29-49. PMC: 6350628. DOI: 10.1039/c8mt00235e. View

14.

Ghazavi A, Kianbakht S, Ghasami K, Mosayebi G . High copper and low zinc serum levels in Iranian patients with multiple sclerosis: a case control study. Clin Lab. 2012; 58(1-2):161-4. View

15.

Hagemeier J, Ramanathan M, Schweser F, Dwyer M, Lin F, Bergsland N . Iron-related gene variants and brain iron in multiple sclerosis and healthy individuals. Neuroimage Clin. 2017; 17:530-540. PMC: 5699896. DOI: 10.1016/j.nicl.2017.11.003. View

16.

Davies K, Bohic S, Carmona A, Ortega R, Cottam V, Hare D . Copper pathology in vulnerable brain regions in Parkinson's disease. Neurobiol Aging. 2013; 35(4):858-66. DOI: 10.1016/j.neurobiolaging.2013.09.034. View

17.

Stephenson E, Nathoo N, Mahjoub Y, Dunn J, Yong V . Iron in multiple sclerosis: roles in neurodegeneration and repair. Nat Rev Neurol. 2014; 10(8):459-68. DOI: 10.1038/nrneurol.2014.118. View

18.

Dringen R, Bishop G, Koeppe M, Dang T, Robinson S . The pivotal role of astrocytes in the metabolism of iron in the brain. Neurochem Res. 2007; 32(11):1884-90. DOI: 10.1007/s11064-007-9375-0. View

19.

Gardner B, Dieriks B, Cameron S, Mendis L, Turner C, Faull R . Metal concentrations and distributions in the human olfactory bulb in Parkinson's disease. Sci Rep. 2017; 7(1):10454. PMC: 5585381. DOI: 10.1038/s41598-017-10659-6. View

20.

Bahrampour Juybari K, Ebrahimi G, Moghaddam M, Asadikaram G, Torkzadeh-Mahani M, Akbari M . Evaluation of serum arsenic and its effects on antioxidant alterations in relapsing-remitting multiple sclerosis patients. Mult Scler Relat Disord. 2017; 19:79-84. DOI: 10.1016/j.msard.2017.11.010. View